Lexeo Therapeutics, Inc. Common Stock(LXEO)
Biotechnology
Gene Therapy & Gene Editing
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | Otero Jose Manuel Chief Operating Officer | Sale | -1,302 | -0.99%130,088 | $5.07 | $6,606 | View SEC filing | |
| 2026-05-20 | Townsend Richard Nolan Chief Executive Officer | Sale | -3,342 | -0.98%336,764 | $5.06 | $16,927 | View SEC filing | |
| 2026-04-07 | Townsend Richard Nolan Chief Executive Officer | Sale | -55,000 | -13.92%340,106 | $5.69 | $313,137 | View SEC filing | |
| 2026-02-20 | Otero Jose Manuel Chief Operating Officer | Sale | -3,016 | -2.35%125,460 | $6.40 | $19,294 | View SEC filing | |
| 2026-02-20 | Otero Jose Manuel Chief Operating Officer | Sale | -721 | -1.12%63,476 | $9.27 | $6,684 | View SEC filing | |
| 2026-02-20 | Townsend Richard Nolan Chief Executive Officer | Sale | -10,173 | -2.53%392,483 | $6.38 | $64,924 | View SEC filing | |
| 2025-11-20 | Otero Jose Manuel Chief Technical Officer | Sale | -721 | -1.12%63,476 | $9.27 | $6,684 | View SEC filing | |
| 2025-11-20 | See Tai Sandi Chief Development Officer | Sale | -386 | -0.59%65,476 | $9.27 | $3,578 | View SEC filing | |
| 2025-11-20 | Townsend Richard Nolan Chief Executive Officer | Sale | -1,127 | -0.47%240,991 | $9.27 | $10,447 | View SEC filing | |
| 2025-11-20 | Robertson Jenny Chief Legal Officer | Sale | -549 | -0.80%68,381 | $9.27 | $5,089 | View SEC filing | |
| 2025-11-20 | Adler Eric Chief Medical Officer | Sale | -615 | -0.84%72,646 | $9.27 | $5,701 | View SEC filing | |
| 2025-10-17 | Otero Jose Manuel Chief Technical Officer | Sale | -2,115 | -3.19%64,197 | $8.94 | $18,913 | View SEC filing | |
| 2025-10-17 | See Tai Sandi Chief Development Officer | Sale | -3,888 | -5.57%65,862 | $8.94 | $34,767 | View SEC filing | |
| 2025-10-17 | Townsend Richard Nolan Chief Executive Officer | Sale | -13,133 | -5.15%242,118 | $8.94 | $117,436 | View SEC filing | |
| 2025-10-17 | Robertson Jenny Chief Legal Officer | Sale | -3,526 | -4.87%68,930 | $8.94 | $31,530 | View SEC filing | |
| 2025-10-17 | Adler Eric Chief Medical Officer | Sale | -3,382 | -4.41%73,261 | $8.94 | $30,242 | View SEC filing | |
| 2025-09-10 | Townsend Richard Nolan Chief Executive Officer | Sale | -1,115 | -0.50%220,058 | $4.67 | $5,205 | View SEC filing | |
| 2025-08-20 | Otero Jose Manuel Chief Technical Officer | Sale | -2,848 | -4.50%60,372 | $4.67 | $13,294 | View SEC filing | |
| 2025-08-20 | Robertson Jenny Chief Legal Officer | Sale | -542 | -0.86%62,556 | $4.67 | $2,530 | View SEC filing | |
| 2025-08-20 | Adler Eric Chief Medical Officer | Sale | -608 | -0.90%67,073 | $4.67 | $2,838 | View SEC filing | |
| 2025-08-20 | Townsend Richard Nolan Chief Executive Officer | Sale | -2,735 | -1.23%220,058 | $4.67 | $12,767 | View SEC filing | |
| 2025-08-20 | See Tai Sandi Chief Development Officer | Sale | -382 | -0.64%58,860 | $4.67 | $1,783 | View SEC filing | |
| 2025-05-20 | Townsend Richard Nolan Chief Executive Officer | Sale | -1,074 | -0.48%221,173 | $2.77 | $2,979 | View SEC filing | |
| 2025-05-20 | Adler Eric Chief Medical Officer | Sale | -585 | -0.86%67,681 | $2.77 | $1,623 | View SEC filing | |
| 2025-05-20 | Robertson Jenny Chief Legal Officer | Sale | -521 | -0.82%63,098 | $2.77 | $1,445 | View SEC filing |
1-25 of 42